Find uplifting stories about heroes, innovations, and solutions
21 results for "wegovy"
Starting June 15, France becomes Europe's first country to fully reimburse medications like Wegovy and Mounjaro. Nearly 10 million French citizens struggling with obesity will now access treatments that previously cost €300 per month.
Scientists discovered that popular weight loss medications like Wegovy might one day treat arthritis by fighting inflammation directly inside joints. This breakthrough could transform how millions manage painful joint conditions.
Diabetes medications like Ozempic and Wegovy may help stop cancer from spreading, according to groundbreaking research tracking over 10,000 cancer patients. The study found these drugs reduced the risk of cancer progression by up to 50% for certain tumor types.
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
The diabetes and weight-loss medication semaglutide (Ozempic/Wegovy) just proved effective at treating alcohol-use disorder in a major clinical trial. Millions struggling with problem drinking now have a new treatment option their doctors already know how to prescribe.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial. This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.
People taking obesity medications like Ozempic and Wegovy report a surprising benefit: the constant mental chatter about food has completely disappeared. Scientists think this discovery could unlock the mystery of what causes obesity.
New research reveals that GLP-1 medications like Wegovy improve heart and liver health even in patients who don't lose weight. The discovery could help millions more people access these life-changing drugs.
New research shows popular weight loss drugs like Wegovy help prevent heart attacks and heal liver disease even in people who don't lose pounds. This discovery could change how millions access life-saving treatment.
Scientists discovered that semaglutide, the drug behind Ozempic and Wegovy, can rebuild damaged cartilage in people with arthritis even without weight loss. The breakthrough hints at a powerful new treatment for millions suffering from joint pain.
A new, more powerful version of Wegovy just got FDA approval and could help people who haven't reached their weight loss goals with standard doses. The higher-dose shot helped study participants lose an extra 8 pounds on average.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
Starting this weekend, affordable generic versions of Ozempic and Wegovy will reach countries representing 40% of the world's population. Prices could eventually drop to $15 per month, making the life-changing medication accessible to millions who couldn't afford it before.
A breakthrough study of 95,000 patients found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces the risk of worsening mental health in people with diabetes and depression. The discovery could offer hope for millions living with both conditions.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Life-changing weight loss and diabetes drugs could soon be made for as little as $3 per month, making them affordable for millions who've been priced out. Patents expire this month in several countries, opening the door to low-cost versions.
People taking weight loss drugs like Wegovy are successfully maintaining their results by spacing out injections to every two weeks instead of weekly. A new study shows most patients kept the weight off and their health improvements without weekly shots.
Millions of Americans have lost significant weight using GLP-1 medications like Ozempic and Wegovy, but keeping it off requires a smart, sustainable plan. Here's the hopeful science behind maintaining your success.
Novo Nordisk's pill version of the blockbuster weight loss drug Wegovy is launching with impressive momentum. The oral alternative to injections could make life-changing treatment easier for millions.
Showing 20 of 21